Proteomics‐based identification of HSP60 as a tumor‐associated antigen in colorectal cancer
Authors:
- 7 March 2007
- journal article
- research article
- Published by Wiley in Proteomics – Clinical Applications
- Vol. 1 (3) , 336-342
Abstract
Patients with cancer frequently develop autoantibodies. The identification of tumor autoantigens may have utility in early cancer diagnosis and immunotherapy. In this study, we used serological proteomics analysis (SERPA) to identify tumor proteins that elicit humoral response in colorectal cancer (CRC). The CRC cell line HCT116 was used as a source of proteins for 2‐DE and subsequent Western blot analysis in which individual serum from patients with CRC was analyzed for autoantibodies. An autoantibody against HSP60 identified by MS was detected in 13 out of 25 patients with CRC and 1 out of 15 healthy subjects. In addition, the HSP60 expressions in tumor tissues collected from 40 patients with CRC were assessed by immunohistochemistry, and serum specimens from 100 patients with cancer and 30 healthy controls were screened for antibody titer to HSP60 by ELISA. The results showed that expressions of HSP60 in tumor tissue and serum antibody titer to HSP60 were significantly higher in patients with CRC than in healthy subjects. Thus, we conclude that the SERPA is an excellent assay for the identification of tumor‐associated antigens and tumor markers. The detection of HSP60 may have clinical utility in CRC screening, diagnosis, and immunotherapy.Keywords
This publication has 32 references indexed in Scilit:
- Tissue expression and sero-reactivity of tumor-specific antigens in colorectal cancerCancer Letters, 2004
- Prevalence of HSP47 antigen and autoantibodies to HSP47 in the sera of patients with mixed connective tissue diseaseBiochemical and Biophysical Research Communications, 2003
- Integrating cancer genomics and proteomics in the post-genome eraProteomics, 2002
- Proteome analysis and its impact on the discovery of serological tumor markersClinica Chimica Acta, 2001
- Contribution of proteomics to tumor immunologyProteomics, 2001
- Proteomic-Based Approach for the Identification of Tumor Markers Associated with Hepatocellular CarcinomaDisease Markers, 2001
- Prognostic significance of circulating antibodies against carcinoembryonic antigen (anti-CEA) in patients with colon cancerAmerican Journal of Gastroenterology, 2000
- Autoantibodies against chaperonin CCT in human sera with rheumatic autoimmune diseases: comparison with antibodies against other Hsp60 family proteinsCell Stress and Chaperones, 2000
- Autoantibodies against the tumour-associated antigen GA733-2 in patients with colorectal carcinomaCancer Immunology, Immunotherapy, 1999
- In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresisAnalytical Biochemistry, 1992